The Evolution of Cancer Treatment in Cuba

In the 1980s, Cuba began investing in cancer vaccine technology to build immunity against infectious agents and has since made significant progress in immunopharmacology.

With advancements in biotechnological drugs, Cuba has also achieved notable breakthroughs in other fields—particularly in cancer treatment.

To combat cancer, which is among the leading causes of death in the country, the Cuban government has developed new cancer treatment methods and vaccines by leveraging biotechnology, genetic engineering, and the expertise of scientists. Cancer treatment in Cuba continues to evolve. The country’s reputation in cancer care and the broader health sector is grounded in the work of well-trained Cuban scientists in biotechnology, molecular pharmacology, and genetic engineering. Their innovative discoveries have led to the development of new vaccines, drugs, and treatment methods.

Cuban research centers support these scientists in the development of cancer vaccines and therapies for other chronic diseases. A key advantage of Cuban cancer vaccines compared to traditional drug treatments is that they help make chemotherapy and radiotherapy more effective while reducing toxicity, thereby minimizing harm to the patient.

In Cuba, biotechnology has transformed cancer from a fatal disease into a manageable chronic condition. The Cuban Center for Immunology focuses on strengthening the immune system through vaccine therapy. It also conducts innovative research and treatments for lung cancer, skin cancer, skin disorders (such as vitiligo), and diabetic foot ulcers resulting from diabetes.

Despite limited resources, the Cuban healthcare system is internationally recognized for providing access to universal healthcare across all segments of society. It also carries out extensive research and development through strategically and financially significant government-funded research centers.